552335-44-1 Usage
Description
(1R,2S)-ethyl 1-((2S,4R)-1-((S)-2-(((tert-butoxy)carbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate is a complex organic compound characterized by its unique arrangement of functional groups and stereochemistry. It features an ethyl ester, a vinylcyclopropane carboxylate, and a pyrrolidine-2-carboxamido group, along with enoyl, hydroxy, and tert-butoxycarbonyl-amino moieties. (1R,2S)-ethyl 1-((2S,4R)-1-((S)-2-(((tert-butoxy)carbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate's stereochemistry is defined by the (1R,2S) and (2S,4R) configurations, which may contribute to its potential applications in various fields such as medicinal chemistry, drug development, and organic synthesis.
Uses
Used in Medicinal Chemistry:
(1R,2S)-ethyl 1-((2S,4R)-1-((S)-2-(((tert-butoxy)carbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate is used as a building block or intermediate in the synthesis of pharmaceutical compounds due to its diverse functional groups and specific stereochemistry, which can be exploited for the development of new drugs with unique mechanisms of action.
Used in Drug Development:
In the pharmaceutical industry, this complex compound serves as a potential candidate for drug development, particularly for targeting specific biological pathways or receptors. Its unique structural features may allow for the design of drugs with enhanced selectivity, potency, and reduced side effects.
Used in Organic Synthesis:
(1R,2S)-ethyl 1-((2S,4R)-1-((S)-2-(((tert-butoxy)carbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate is utilized as a versatile reactant in organic synthesis, enabling the creation of a wide range of chemical products. Its multiple functional groups and stereochemical configurations provide opportunities for various synthetic routes and the formation of novel molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 552335-44-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,2,3,3 and 5 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 552335-44:
(8*5)+(7*5)+(6*2)+(5*3)+(4*3)+(3*5)+(2*4)+(1*4)=141
141 % 10 = 1
So 552335-44-1 is a valid CAS Registry Number.
552335-44-1Relevant articles and documents
Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease
Jiang, Yutong,Andrews, Steven W.,Condroski, Kevin R.,Buckman, Brad,Serebryany, Vlad,Wenglowsky, Steve,Kennedy, April L.,Madduru, Machender R.,Wang, Bin,Lyon, Michael,Doherty, George A.,Woodard, Benjamin T.,Lemieux, Christine,Do, Mary Geck,Zhang, Hailong,Ballard, Joshua,Vigers, Guy,Brandhuber, Barbra J.,Stengel, Peter,Josey, John A.,Beigelman, Leonid,Blatt, Lawrence,Seiwert, Scott D.
, p. 1753 - 1769 (2014/04/03)
HCV serine protease NS3 represents an attractive drug target because it is not only essential for viral replication but also implicated in the viral evasion of the host immune response pathway through direct cleavage of key proteins in the human innate im
Inhibitors of Hepatitis C Virus
-
, (2008/12/04)
Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS
-
, (2008/12/05)
Macrocyclic peptides having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.